View Item 

Show simple item record

Guidelines for the Diagnosis of Antibody‐Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schema

dc.contributor.authorDrachenberg, C. B.en_US
dc.contributor.authorTorrealba, J. R.en_US
dc.contributor.authorNankivell, B. J.en_US
dc.contributor.authorRangel, E. B.en_US
dc.contributor.authorBajema, I. M.en_US
dc.contributor.authorKim, D. U.en_US
dc.contributor.authorArend, L.en_US
dc.contributor.authorBracamonte, E. R.en_US
dc.contributor.authorBromberg, J. S.en_US
dc.contributor.authorBruijn, J. A.en_US
dc.contributor.authorCantarovich, D.en_US
dc.contributor.authorChapman, J. R.en_US
dc.contributor.authorFarris, A. B.en_US
dc.contributor.authorGaber, L.en_US
dc.contributor.authorGoldberg, J. C.en_US
dc.contributor.authorHaririan, A.en_US
dc.contributor.authorHonsová, E.en_US
dc.contributor.authorIskandar, S. S.en_US
dc.contributor.authorKlassen, D. K.en_US
dc.contributor.authorKraus, E.en_US
dc.contributor.authorLower, F.en_US
dc.contributor.authorOdorico, J.en_US
dc.contributor.authorOlson, J. L.en_US
dc.contributor.authorMittalhenkle, A.en_US
dc.contributor.authorMunivenkatappa, R.en_US
dc.contributor.authorParaskevas, S.en_US
dc.contributor.authorPapadimitriou, J. C.en_US
dc.contributor.authorRandhawa, P.en_US
dc.contributor.authorReinholt, F. P.en_US
dc.contributor.authorRenaudin, K.en_US
dc.contributor.authorRevelo, P.en_US
dc.contributor.authorRuiz, P.en_US
dc.contributor.authorSamaniego, Millie D.en_US
dc.contributor.authorShapiro, R.en_US
dc.contributor.authorStratta, R. J.en_US
dc.contributor.authorSutherland, David E. R.en_US
dc.contributor.authorTroxell, M. L.en_US
dc.contributor.authorVoska, L.en_US
dc.contributor.authorSeshan, S. V.en_US
dc.contributor.authorRacusen, L. C.en_US
dc.contributor.authorBartlett, S. T.en_US
dc.date.accessioned2011-11-10T15:38:41Z
dc.date.available2012-11-02T18:56:49Zen_US
dc.date.issued2011-09en_US
dc.identifier.citationDrachenberg, C. B.; Torrealba, J. R.; Nankivell, B. J.; Rangel, E. B.; Bajema, I. M.; Kim, D. U.; Arend, L.; Bracamonte, E. R.; Bromberg, J. S.; Bruijn, J. A.; Cantarovich, D.; Chapman, J. R.; Farris, A. B.; Gaber, L.; Goldberg, J. C.; Haririan, A.; Honsová, E. ; Iskandar, S. S.; Klassen, D. K.; Kraus, E.; Lower, F.; Odorico, J.; Olson, J. L.; Mittalhenkle, A.; Munivenkatappa, R.; Paraskevas, S.; Papadimitriou, J. C.; Randhawa, P.; Reinholt, F. P.; Renaudin, K.; Revelo, P.; Ruiz, P.; Samaniego, M. D.; Shapiro, R.; Stratta, R. J.; Sutherland, D. E. R.; Troxell, M. L.; Voska, L.; Seshan, S. V.; Racusen, L. C.; Bartlett, S. T. (2011). "Guidelines for the Diagnosis of Antibodyâ Mediated Rejection in Pancreas Allograftsâ Updated Banff Grading Schema." American Journal of Transplantation 11(9). <http://hdl.handle.net/2027.42/87117>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87117
dc.publisherBlackwell Publishing Incen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherAcinar Cell Injuryen_US
dc.subject.otherActive Chronic Antibody‐Mediated Rejectionen_US
dc.subject.otherAmylinen_US
dc.subject.otherAmyloiden_US
dc.subject.otherC4den_US
dc.subject.otherCell‐Mediated Rejectionen_US
dc.subject.otherDonor‐Specific Antibodyen_US
dc.subject.otherInteracinar Capillariesen_US
dc.subject.otherPancreas Biopsyen_US
dc.subject.otherTransplant Arteriopathyen_US
dc.titleGuidelines for the Diagnosis of Antibody‐Mediated Rejection in Pancreas Allografts—Updated Banff Grading Schemaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDepartment of Pathology, University of Maryland School of Medicine, Baltimore, MDen_US
dc.contributor.affiliationotherDepartment of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin‐Madison, Madison, WIen_US
dc.contributor.affiliationotherDepartment of Renal Medicine, University of Sidney, Westmead Hospital, Sydney, Australiaen_US
dc.contributor.affiliationotherPancreas‐Kidney Transplantation Unit, Hospital Israelita Albert Einstein, HIAE, San Paulo, Brazilen_US
dc.contributor.affiliationotherDepartment of Pathology, Leiden University Medical Center, Leiden, the Netherlandsen_US
dc.contributor.affiliationotherDepartment of Pathology, Saint Barnabas Medical Center, Livingston, NJen_US
dc.contributor.affiliationotherDepartment of Pathology (L.A. and L.C.R.) and Internal Medicine (E.K.), Johns Hopkins University, Baltimore, MDen_US
dc.contributor.affiliationotherDepartment of Pathology, University of Arizona, Tucson, AZen_US
dc.contributor.affiliationotherDepartment of Surgery, University of Maryland School of Medicine, Baltimore, MDen_US
dc.contributor.affiliationotherDepartment of Nephrology (D.C.) and Department of Pathology (K.R.) CHU – Hôtel Dieu, Nantes, Franceen_US
dc.contributor.affiliationotherDepartment of Pathology, Emory University School of Medicine, Atlanta, GAen_US
dc.contributor.affiliationotherDepartment of Pathology, The Methodist Hospital, Weil Cornell Medical College, Houston, TXen_US
dc.contributor.affiliationotherInstituto de Nefrologia, Buenos Aires, Argentinaen_US
dc.contributor.affiliationotherDepartment of Medicine, University of Maryland School of Medicine, Baltimore, MDen_US
dc.contributor.affiliationotherDepartment of Pathology, Institute for Clinical and Experimental Medicine, Prague, Czech Republicen_US
dc.contributor.affiliationotherDepartment of Pathology (S.I.) and General Surgery (R.J.S.) Wake Forest University School of Medicine, Winston‐Salem, NCen_US
dc.contributor.affiliationotherSouthern Illinois University School of Medicine, Springfield, ILen_US
dc.contributor.affiliationotherDepartment of Surgery, School of Medicine and Public Health, University of Wisconsin‐Madison, Madison, WIen_US
dc.contributor.affiliationotherDepartment of Pathology, University of California, San Francisco, CAen_US
dc.contributor.affiliationotherDepartment of Medicine (A.M.) and Department of Pathology (M.L.T.), Division of Nephrology & Hypertension, Oregon Health & Science University, Portland, ORen_US
dc.contributor.affiliationotherDepartment of Surgery, McGill University, Montreal, Quebec, Canadaen_US
dc.contributor.affiliationotherDepartment of Pathology (P.R.) and Department of Surgery (R.S.), Division of Transplantation Pathology, University of Pittsburgh, Pittsburgh, PAen_US
dc.contributor.affiliationotherDepartment of Pathology, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norwayen_US
dc.contributor.affiliationotherDepartment of Pathology and Laboratory Medicine, University of Utah, Salt Lake City, UTen_US
dc.contributor.affiliationotherDepartments of Pathology and Surgery, University of Miami, Miami, FLen_US
dc.contributor.affiliationotherDepartment of Surgery, Division of Transplantation and Diabetes Institute for Immunology and Transplantation, University of Minnesota, Minneapolis, MNen_US
dc.contributor.affiliationotherDepartment of Pathology, Weil Cornell Medical College, New York, NYen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87117/1/j.1600-6143.2011.03670.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2011.03670.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceGruessner AC, Sutherland DE, Gruessner RW. Pancreas transplantation in the United States: A review. Curr Opin Organ Transplant 2010; 15: 93 – 101.en_US
dc.identifier.citedreferenceDrachenberg CB, Papadimitriou JC, Farney A, et al. Pancreas transplantation: The histologic morphology of graft loss and clinical correlations. Transplantation 2001; 71: 1784 – 1791.en_US
dc.identifier.citedreferenceLuan FL, Trillsch F, Henger A, et al. A pilot study of gene expression‐based categorization of pancreas transplant biopsies. Transplantation 2009; 87: 222 – 226.en_US
dc.identifier.citedreferenceNakhleh RE, Sutherland DE. Biopsies from pancreas allografts at time of dysfunction: Pathologic comparison of allografts which ultimately failed versus those which continued to function. Transplant Proc 1993; 25 ( 1 Pt 2 ): 1194 – 1195.en_US
dc.identifier.citedreferencePapadimitriou JC, Drachenberg CB, Klassen DK, et al. Histological grading of chronic pancreas allograft rejection/graft sclerosis. Am J Transplant 2003; 3: 599 – 605.en_US
dc.identifier.citedreferenceTorrealba JR, Samaniego M, Pascual J, et al. C4d‐positive interacinar capillaries correlates with donor‐specific antibody‐mediated rejection in pancreas allografts. Transplantation 2008; 86: 1849 – 1856.en_US
dc.identifier.citedreferenceTroxell ML, Koslin DB, Norman D, et al. Pancreas allograft rejection: Analysis of concurrent renal allograft biopsies and posttherapy follow‐up biopsies. Transplantation 2010; 90: 75 – 84.en_US
dc.identifier.citedreferenceDrachenberg CB, Papadimitriou JC, Klassen DK, et al. Evaluation of pancreas transplant needle biopsy: Reproducibility and revision of histologic grading system. Transplantation 1997; 63: 1579 – 1586.en_US
dc.identifier.citedreferenceDrachenberg CB, Odorico J, Demetris AJ, et al. Banff schema for grading pancreas allograft rejection: Working proposal by a multi‐disciplinary international consensus panel. Am J Transplant 2008; 8: 1237 – 1249.en_US
dc.identifier.citedreferenceWaki K, Terasaki PI, Kadowaki T. Long term pancreas allograft survival in simultaneous pancreas kidney transplantation by era: UNOS registry analysis. Diabetes Care 2010; 33: 1789 – 1791.en_US
dc.identifier.citedreferencePascual J, Samaniego MD, Torrealba JR, et al. Antibody‐mediated rejection of the kidney after simultaneous pancreas‐kidney transplantation. J Am Soc Nephrol 2008; 19: 812 – 824.en_US
dc.identifier.citedreferencede Kort H, Munivenkatappa RB, Berger SP, et al. Pancreas allograft biopsies with positive C4d staining and anti‐donor antibodies related to worse outcome for patients. Am J Transplant 2010; 10: 1660 – 1667.en_US
dc.identifier.citedreferenceMelcher ML, Olson JL, Baxter‐Lowe LA, et al. Antibody‐mediated rejection of a pancreas allograft. Am J Transplant 2006; 6: 423 – 428.en_US
dc.identifier.citedreferenceMunivenkatappa RB, Philosophe B, Papadimitriou JC, et al. Interacinar c4d staining in pancreas allografts. Transplantation 2009; 88: 145 – 146.en_US
dc.identifier.citedreferenceRangel EB, Malheiros DM, de Castro MC, et al. Antibody‐mediated rejection (AMR) after pancreas and pancreas‐kidney transplantation. Transpl Int 2010; 23: 602 – 610.en_US
dc.identifier.citedreferenceColvin RB. Dimensions of antibody‐mediated rejection. Am J Transplant 2010; 10: 1509 – 1510.en_US
dc.identifier.citedreferenceColvin RB. Antibody‐mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046 – 1056.en_US
dc.identifier.citedreferenceGaber LW. Pancreas allograft biopsies in the management of pancreas transplant recipients: Histopathologic review and clinical correlations. Arch Pathol Lab Med 2007; 131: 1192 – 1199.en_US
dc.identifier.citedreferenceFabio V, Daniele F, Monica DD, et al. Pancreas rejection after pandemic influenzavirus A(H(1) N(1)) vaccination or infection: A report of two cases. Transpl Int 2011; 24: e28 – e29.en_US
dc.identifier.citedreferenceZanone MM, Favaro E, Quadri R, et al. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient. Transpl Int 2010; 23: 333 – 337.en_US
dc.identifier.citedreferenceEinecke G, Sis B, Reeve J, et al. Antibody‐mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520 – 2531.en_US
dc.identifier.citedreferencePapadimitriou JC, Drachenberg CB, Munivenkatappa R, et al. Glomerular inflammation in renal allografts biopsies after the first year: Cell types and relationship with antibody‐mediated rejection and graft outcome. Transplantation 2010; 90: 1478 – 1485.en_US
dc.identifier.citedreferenceEverly MJ, Rebellato LM, Ozawa M, et al. Beyond histology: Lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation 2010; 89: 962 – 967.en_US
dc.identifier.citedreferenceTerasaki PI. The review by Kwun and Knechtle‐“can it B?” ‐asks whether B cells are responsible for chronic rejection of transplants. Transplantation 2009; 88; 978 – 979.en_US
dc.identifier.citedreferencePorcheray F, DeVito J, Yeap BY, et al. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 2010; 89: 1239 – 1246.en_US
dc.identifier.citedreferencePelletier RP, Hennessy PK, Adams PW, et al. Clinical significance of MHC‐reactive alloantibodies that develop after kidney or kidney‐pancreas transplantation. Am J Transplant 2002; 2: 134 – 141.en_US
dc.identifier.citedreferenceDaar AS, Fuggle SV, Fabre JW, et al. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation 1984; 38: 293 – 298.en_US
dc.identifier.citedreferenceDaar AS, Fuggle SV, Fabre JW, et al. The detailed distribution of HLA‐A, B, C antigens in normal human organs. Transplantation 1984; 38: 287 – 292.en_US
dc.identifier.citedreferenceFleming KA, McMichael A, Morton JA, et al. Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer. J Clin Pathol 1981; 34: 779 – 784.en_US
dc.identifier.citedreferenceJackson AM, Connolly JE, Matsumoto S, et al. Evidence for induced expression of HLA Class II on human islets: Possible mechanism for HLA sensitization in transplant recipients. Transplantation 2009; 87: 500 – 506.en_US
dc.identifier.citedreferencePavlovic D, van de Winkel M, van der Auwera B, et al. Effect of interferon‐gamma and glucose on major histocompatibility complex class I and class II expression by pancreatic beta‐ and non‐beta‐cells. J Clin Endocrinol Metab 1997; 82: 2329 – 2336.en_US
dc.identifier.citedreferencePujol‐Borrell R, Todd I, Doshi M, Gray D, et al. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas. Clin Exp Immunol 1986; 65: 128 – 139.en_US
dc.identifier.citedreferenceSteiniger B, Klempnauer J, Wonigeit K. Altered distribution of class I and class II MHC antigens during acute pancreas allograft rejection in the rat. Transplantation 1985; 40: 234 – 239.en_US
dc.identifier.citedreferenceFoulis AK, Farquharson MA, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of class I major histocompatibility complex molecules by insulin containing islets in type 1 (insulin‐dependent) diabetes mellitus. Diabetologia 1987; 30: 333 – 343.en_US
dc.identifier.citedreferenceGaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody‐mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68 – 74.en_US
dc.identifier.citedreferenceHowell WM, Harmer A, Briggs D, et al. British Society for Histocompatibility & Immunogenetics and British Transplantation Society guidelines for the detection and characterisation of clinically relevant antibodies in allotransplantation. Int J Immunogenet 2010; 37: 435 – 437.en_US
dc.identifier.citedreferenceZeevi A, Lunz JG, 3rd, Shapiro R, et al. Emerging role of donor‐specific anti‐human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 2009; 70: 645 – 650.en_US
dc.identifier.citedreferenceLeffell MS, Zachary AA. Antiallograft antibodies: Relevance, detection, and monitoring. Curr Opin Organ Transplant 2010; 15: 2 – 7.en_US
dc.identifier.citedreferenceZou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney‐transplant rejection. N Engl J Med 2007; 357: 1293 – 1300.en_US
dc.identifier.citedreferenceFeucht HE, Opelz G. The humoral immune response towards HLA class II determinants in renal transplantation. Kidney Int 1996; 50: 1464 – 1475.en_US
dc.identifier.citedreferenceMinami K, Murata K, Lee CY, et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006; 6 ( 5 Pt 1 ): 923 – 932.en_US
dc.identifier.citedreferenceHalloran PF, de Freitas DG, Einecke G, et al. The molecular phenotype of kidney transplants. Am J Transplant 2010; 10: 2215 – 2222.en_US
dc.identifier.citedreferenceSis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d‐negative antibody‐mediated rejection. Curr Opin Organ Transplant 2010; 15: 42 – 48.en_US
dc.identifier.citedreferenceLoupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor‐specific antibodies (DSA). Am J Transplant 2011; 11: 56 – 65.en_US
dc.identifier.citedreferenceSolez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753 – 760.en_US
dc.identifier.citedreferenceMiller DV, Roden AC, Gamez JD, et al. Detection of C4d deposition in cardiac allografts: A comparative study of immunofluorescence and immunoperoxidase methods. Arch Pathol Lab Med 2010; 134: 1679 – 1684.en_US
dc.identifier.citedreferenceHaririan A, Kiangkitiwan B, Kukuruga D, et al. The impact of c4d pattern and donor‐specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009; 9: 2758 – 2767.en_US
dc.identifier.citedreferenceTroppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: Univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996; 182: 285 – 316.en_US
dc.identifier.citedreferenceSibley RK. Pancreas transplantation. In: Sale GE, ed. The pathology of organ transplantation. Boston: Butterworth Publishers, 1990: 179 – 215.en_US
dc.identifier.citedreferenceHawthorne WJ, Griffin AD, Lau H, et al. Experimental hyperacute rejection in pancreas allotransplants. Transplantation 1996; 62: 324 – 329.en_US
dc.identifier.citedreferenceHeilman RL, Chakkera H, Mazur M, et al. Outcomes of simultaneous kidney‐pancreas transplantation with positive cross‐match. Transplant Proc 2009; 41: 303 – 306.en_US
dc.identifier.citedreferenceKhwaja K, Wijkstrom M, Gruessner A, et al. Pancreas transplantation in crossmatch‐positive recipients. Clin Transplant 2003; 17: 242 – 248.en_US
dc.identifier.citedreferenceLitmathe J, Bektas H, Jorns A, et al. Time frame of pancreas allograft rejection: An immunogenetic analysis in MHC‐disparate, presensitized inbred rat strains. Transplant Proc 2003; 35: 3147 – 3152.en_US
dc.identifier.citedreferencePascual J, Pirsch JD, Odorico JS, et al. Alemtuzumab induction and antibody‐mediated kidney rejection after simultaneous pancreas‐kidney transplantation. Transplantation 2009; 87: 125 – 132.en_US
dc.identifier.citedreferencePrikis M, Norman D, Rayhill S, et al. Preserved endocrine function in a pancreas transplant recipient with pancreatic panniculitis and antibody‐mediated rejection. Am J Transplant 2010; 10: 2717 – 2722.en_US
dc.identifier.citedreferenceGibson IW, Gwinner W, Brocker V, et al. Peritubular capillaritis in renal allografts: Prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8: 819 – 825.en_US
dc.identifier.citedreferenceLiptak P, Kemeny E, Morvay Z, et al. Peritubular capillary damage in acute humoral rejection: An ultrastructural study on human renal allografts. Am J Transplant 2005; 5: 2870 – 2876.en_US
dc.identifier.citedreferenceCarbajal R, Karam G, Renaudin K, et al. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation. Nephrol Dial Transplant 2007; 22: 942 – 944.en_US
dc.identifier.citedreferenceHirohashi T, Uehara S, Chase CM, et al. Complement independent antibody‐mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010; 10: 510 – 517.en_US
dc.identifier.citedreferenceShimizu T, Ishida H, Shirakawa H, et al. Clinicopathological analysis of acute vascular rejection cases after renal transplantation. Clin Transplant 2010; 24 ( Suppl 22 ): 22 – 26.en_US
dc.identifier.citedreferenceSis B, Einecke G, Chang J, et al. Cluster analysis of lesions in nonselected kidney transplant biopsies: Microcirculation changes, tubulointerstitial inflammation and scarring. Am J Transplant 2010; 10: 421 – 430.en_US
dc.identifier.citedreferenceVendrame F, Pileggi A, Laughlin E, et al. Recurrence of type 1 diabetes after simultaneous pancreas‐kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T‐cells. Diabetes 2010; 59: 947 – 957.en_US
dc.identifier.citedreferenceTyden G, Reinholt FP, Sundkvist G, et al. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860 – 863.en_US
dc.identifier.citedreferenceCai K, Qi D, Wang O, et al. TNF‐alpha acutely upregulates amylin expression in murine pancreatic beta cells. Diabetologia 2011; 54: 617 – 626.en_US
dc.identifier.citedreferenceJaikaran ET, Clark A. Islet amyloid and type 2 diabetes: From molecular misfolding to islet pathophysiology. Biochim Biophys Acta 2001; 1537: 179 – 203.en_US
dc.identifier.citedreferenceSis B, Mengel M, Haas M, et al. Banff ‘09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464 – 471.en_US
dc.identifier.citedreferenceHalloran PF, de Freitas DG, Einecke G, et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010; 10: 2223 – 2230.en_US
dc.identifier.citedreferenceSis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody‐mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312 – 2323.en_US
dc.identifier.citedreferenceStegall MD, Gloor JM. Deciphering antibody‐mediated rejection: New insights into mechanisms and treatment. Curr Opin Organ Transplant 2010; 15: 8 – 10.en_US
dc.identifier.citedreferenceMengel M, Sis B, Halloran PF. SWOT analysis of Banff: Strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7: 2221 – 2226.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2011.03670.x.pdf
Size:
629.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.